Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹-8.16 Cr₹-6.74 Cr₹-6.29 Cr₹4.11 Cr₹13 Cr

What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH is ₹-8.16 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹-8.16 Cr
Mar2024₹-6.74 Cr
Mar2023₹-6.29 Cr
Mar2022₹4.11 Cr
Mar2021₹13 Cr

How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹-8.16 Cr
Negative
Mar2024 ₹-6.74 Cr
Negative
Mar2023 ₹-6.29 Cr
Negative
Mar2022 ₹4.11 Cr
-67.83
Mar2021 ₹13 Cr -

Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹341.5 Cr -8% -24.8% -36.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-8%

-24.8%

-36.4%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses